4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-16-118528
Chief Executive Officer gave up 116,667 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2016-05-05 | Shares withheld for taxes | −116,667 | $6.86 | $800,336 | 1,014,333 | D |
Loading xslF345X03/doc4.xml…